Volume -                   3 , - : 47-55 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Aging vs Alzheimer’s Disorders and Medicaments in Developing World. 3 https://doi.org/10.58209/gmjm.3.2.47
URL: http://daneshafarand.org/article-1-223-en.html
Abstract:   (593 Views)
Introduction: The present article exposes the relationship between aging and facing Alzheimer's disorders among an increasing number of people, with special reference to developing countries. In modern times, many developing countries benefit from more access to hygiene, medicine, education, communications, social networks, and the like. All such factors have determining roles in people's aging and life expectancy. For example, many Asian countries have doubled or tripled the number of elderly citizens between 1995 and 2015. Therefore, aging is undoubtedly increasing, while medicaments and geriatrics are not increasing at the same rate-leaving behind increasing Alzheimer's disorders. Trouble is even much more over the age of 65, when one of the two (couple) is dead, and the remaining person must self-control himself. So, developing countries must invest further in medicine and geriatrics for people aged 65 and beyond.
Conclusion: It must be accepted as a gerontological fact that aging is ever-enlarging and extending and requires further means of coping.
 
  |   |   Full-Text (HTML)  (121 Views)  
Article Type: Analytical Review | Subject: Biotechnology

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.